Resultados de la búsqueda 31-40 of 14507 for Orthostatic hypotension

  1. Ensayos clínicos - Neurología

    Droxidopa / Pyridostigmine In Orthostatic Hypotension. Rochester, Minn. The hypothesis is that pyridostigmine will improve the safety factor of ganglionic ...

  2. Ensayos clínicos - Neurología

    Droxidopa / Pyridostigmine In Orthostatic Hypotension. Rochester, Minn. The hypothesis is that pyridostigmine will improve the safety factor of ganglionic ...

  3. Neurología - Ensayos clínicos

    A Study of Norfolk Quality of Life-diabetic Neuropathy in Diabetic Lumbosacral Radiculoplexus Neuropathy · Droxidopa / Pyridostigmine In Orthostatic Hypotension.

  4. Neurología - Ensayos clínicos - Mayo Clinic

    Droxidopa / Pyridostigmine In Orthostatic Hypotension. Rochester, Minn. The hypothesis is that pyridostigmine will improve the safety factor of ganglionic ...

  5. Neurología - Ensayos clínicos - Mayo Clinic

    Droxidopa / Pyridostigmine In Orthostatic Hypotension. Rochester, Minn. The hypothesis is that pyridostigmine will improve the safety factor of ganglionic ...

  6. Neurología - Ensayos clínicos - Mayo Clinic

    Droxidopa / Pyridostigmine In Orthostatic Hypotension. Rochester, Minn. The hypothesis is that pyridostigmine will improve the safety factor of ganglionic ...

  7. Neurología - Ensayos clínicos

    Droxidopa / Pyridostigmine In Orthostatic Hypotension. Rochester, Minn. The hypothesis is that pyridostigmine will improve the safety factor of ganglionic ...

  8. Neurología - Ensayos clínicos - Mayo Clinic

    Droxidopa / Pyridostigmine In Orthostatic Hypotension. Rochester, Minn. The hypothesis is that pyridostigmine will improve the safety factor of ganglionic ...

  9. Neurología - Ensayos clínicos

    Droxidopa / Pyridostigmine In Orthostatic Hypotension. Rochester, Minn. The hypothesis is that pyridostigmine will improve the safety factor of ganglionic ...

  10. Ensayos clínicos - Neurología

    Droxidopa / Pyridostigmine In Orthostatic Hypotension. Rochester, Minn. The hypothesis is that pyridostigmine will improve the safety factor of ganglionic ...